Virtus ETF Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Virtus ETF Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$780K	Sell	13,539 -176	-1%	-$10.1K	0.3%	79
2026 Q1	$832K	Sell	13,715 -402	-3%	-$23.4K	0.39%	53
2025 Q4	$761K	Buy	14,117 +1,767	+14%	+$85K	0.36%	64
2025 Q3	$557K	Buy	+12,350	New	+$577K	0.31%	90
2023 Q3	–	Sell	-11,124	Closed	-$711K	–	440
2023 Q2	$711K	Sell	11,124 -989	-8%	-$66.3K	0.42%	108
2023 Q1	$840K	Buy	12,113 +1,412	+13%	+$99.6K	0.46%	87
2022 Q4	$770K	Buy	10,701 +1,399	+15%	+$105K	0.4%	92
2022 Q3	$661K	Sell	9,302 -402	-4%	-$29.2K	0.26%	132
2022 Q2	$747K	Buy	+9,704	New	+$739K	0.28%	98
2020 Q3	–	Sell	-1,142	Closed	-$67K	–	336
2020 Q2	$67K	Buy	1,142 +725	+174%	+$43.4K	0.03%	334
2020 Q1	$23K	Sell	417 -502	-55%	-$30.7K	0.01%	323
2019 Q4	$59K	Buy	+919	New	+$52.6K	0.01%	296

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virtus ETF Advisers's BMY Position: Q2 2026 in Review

Virtus ETF Advisers reduced its Bristol-Myers Squibb (BMY) stake by 1.3% in Q2 2026, selling an estimated $10.1K and leaving 13,539 shares worth $780K. The position accounts for 0.3% of the portfolio, ranked #79.

Virtus ETF Advisers first reported a position in BMY in Q4 2019 and has held it in 12 quarters since. The position peaked at $840K in Q1 2023. 2,516 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Virtus ETF Advisers held 13,539 shares of Bristol-Myers Squibb worth $780K as of Q2 2026.
Virtus ETF Advisers sold 176 Bristol-Myers Squibb shares in Q2 2026, an estimated $10.1K.
Bristol-Myers Squibb made up 0.3% of Virtus ETF Advisers's portfolio in Q2 2026, its #79 holding.
Virtus ETF Advisers first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 12 quarters since.
Virtus ETF Advisers's Bristol-Myers Squibb position peaked at $840K in Q1 2023.
2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.